Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Coagulation

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emerging viral infections: role of flavivirus NS1-mediated rewiring of PRR signaling.

European cytokine network·2026

Same author

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

WWOX-Related Epileptic Encephalopathy (WOREE Syndrome): Clinical Case Study and Literature Review.

Current issues in molecular biology·2026

Same author

Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts.

Science translational medicine·2026

Same author

Editorial: HLA-G in health and disease: comprehensive insights and future therapeutic directions.

Frontiers in immunology·2026

Same author

SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile.

Microorganisms·2026

Search research articles

Related Experiment Video

Updated: Jan 9, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

Flavivirus Nonstructural Protein 1‑Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study.

Silvia Beltrami¹, Matteo Ferraresi¹, Giorgia Cianci¹

¹Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara 44121, Italy.

|December 1, 2025

Summary

Flavivirus nonstructural protein sNS1 influences blood clotting and inflammation differently depending on the virus type. Neurotropic flavivirus sNS1 promotes clotting, while hemorrhagic flavivirus sNS1 inhibits it, impacting disease severity.

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

Related Experiment Videos

Last Updated: Jan 9, 2026

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

Area of Science:

Virology
Immunology
Hematology

Background:

Flaviviruses cause significant global health issues with varied clinical outcomes.
The secreted nonstructural protein 1 (sNS1) is implicated in flavivirus pathogenesis.
sNS1's role in modulating host coagulation and inflammation remains incompletely understood.

Purpose of the Study:

To investigate the differential effects of sNS1 from neurotropic and hemorrhagic flaviviruses on coagulation and inflammation.
To explore the underlying mechanisms of sNS1-mediated vascular changes.

Main Methods:

Utilized human monocytic (THP-1) cells to study sNS1-host interactions.
Assessed tissue factor (TF) expression and TF-bearing microvesicle release.
Measured levels of inflammatory cytokine, interleukin-6 (IL-6).

Main Results:

sNS1 from neurotropic flaviviruses (e.g., West Nile virus) increased TF expression and procoagulant activity.
sNS1 from hemorrhagic flaviviruses (e.g., dengue virus) exhibited anticoagulant effects.
Divergent sNS1 activities correlated with differential IL-6 modulation, highlighting inflammation's role.

Conclusions:

Flavivirus sNS1 is a critical virulence factor modulating host hemostasis and immunity.
Virus-specific sNS1 activities contribute to diverse flavivirus clinical manifestations.
sNS1 represents a potential therapeutic target for flavivirus infections.